Create Health
1001 – 1010 of 1017
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1993
-
Mark
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
(
- Contribution to journal › Article
- 1992
-
Mark
Epstein-Barr virus-induced transformation of human B lymphocytes : the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations
(
- Contribution to journal › Article
-
Mark
Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope
(
- Contribution to journal › Article
-
Mark
Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis
(
- Contribution to journal › Article
-
Mark
Kinetic analysis of recombinant antibody-antigen interactions : Relation between structural domains and antigen binding
(
- Contribution to journal › Article
-
Mark
Evaluation of the degradation of desamino1,D-arginine8-vasopressin by nasal mucosa.
(
- Contribution to journal › Article
-
Mark
Human monoclonal antibody technology. A tool to investigate human antibody repertoires.
1992)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies.
(
- Contribution to journal › Article
-
Mark
Real time analysis of antibody-antigen reaction kinetics.
(
- Contribution to journal › Article
- 1991
-
Mark
Human monoclonal antibodies with different fine-specificity for digoxin derivatives: Cloning of heavy and light chain variable region sequences
(
- Contribution to journal › Article